Trials / Completed
CompletedNCT06715696
The Hemostatic Effectiveness of "HANBIO" Gauze During Non-emergent Gynecology Surgery.
Clinical Hemostatic Effectiveness of PET-Collagen Gauze ("HANBIO" Gauze) for Acute Wound: a Prospective, Single-arm, Open-label Evaluation Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- HAN Biomedical Inc · Industry
- Sex
- Female
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to collect the hemostatic effectiveness and device safety data of "HANBIO" Gauze in subjects have acute wound result from gynecology surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | "HANBIO" Gauze (Sterilized, 1% Collagen) | After tissue resection in a standard procedure for gynecological surgery, direct application of "HANBIO" Gauze to cover the bleeding site/area which identified during dissection. |
Timeline
- Start date
- 2024-12-15
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
- First posted
- 2024-12-04
- Last updated
- 2025-05-29
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06715696. Inclusion in this directory is not an endorsement.